Effect of l-5-hydroxytryptophan on brain monoamine metabolism and evaluation of its clinical effect in depressed patients.
D006916:5-Hydroxytryptophan / Q000494:pharmacology / Q000627:therapeutic use*; D000275:Adjustment Disorders / Q000188:drug therapy / Q000378:metabolism; D000328:Adult; D000368:Aged; D001792:Blood Platelets / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D003863:Depression / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D007536:Isomerism; D008297:Male; D008787:Metoclopramide / Q000627:therapeutic use; D008875:Middle Aged; D009325:Nausea / Q000517:prevention & control; D011569:Psychiatric Status Rating Scales; D012701:Serotonin / Q000378:metabolism*; D012737:Sex Factors
D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D006916:5-Hydroxytryptophan; D008787:Metoclopramide; D006719:Homovanillic Acid